University of Texas MD Anderson Cancer Center


Hospital

Location:
Houston, United States (USA)


Publications in cooperation with FAU scientists


Go to first page Go to previous page 1 of 5 Go to next page Go to last page
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., Seiler, R., Williams, S.B., & Schmitz-Dräger, B.J. (2019). Editorial: Basic research in bladder cancer – refining the tools. 3rd IBCN seminars series1. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.01.003
Seiler, R., Black, P.C., Williams, S.B., Goebell, P., Kamat, A.M., Nawroth, R., & Schmitz-Dräger, B.J. (2019). Editorial: Bladder cancer within the focus of basic and clinical research. Sixth IBCN Seminars Series. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2019.06.025
Cameron, J.M., Maljevic, S., Nair, U., Aung, Y.H., Cogne, B., Bezieau, S.,... Berkovic, S.F. (2019). Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations. Annals of Clinical and Translational Neurology. https://dx.doi.org/10.1002/acn3.50822
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-17-3864
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Yao, J., Garg, A., Chen, D., Capdevila, J., Engstrom, P., Pommier, R.,... Kulke, M.H. (2019). Genomic profiling of NETs: a comprehensive analysis of the RADIANT trials. Endocrine-Related Cancer, 26(4), 391-403. https://dx.doi.org/10.1530/ERC-18-0332
Wang, E.W., Zanation, A.M., Gardner, P.A., Schwartz, T.H., Eloy, J.A., Adappa, N.D.,... Van Koevering, K. (2019). ICAR: endoscopic skull-base surgery. International Forum of Allergy and Rhinology, 9, S145-S365. https://dx.doi.org/10.1002/alr.22326
Jain, P., Finger, P.T., Damato, B., Coupland, S.E., Heimann, H., Kenawy, N.,... Yin, V. (2019). Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmology, 137(8), 905-911. https://dx.doi.org/10.1001/jamaophthalmol.2019.1640
Hurvitz, S.A., Martin, M., Jung, K.H., Huang, C.S., Harbeck, N., Valero, V.,... Slamon, D. (2019). Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study. Journal of Clinical Oncology, 37(25), 2206-2216. https://dx.doi.org/10.1200/JCO.19.00882
Boormans, J.L., Zwarthoff, E.C., Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R.,... Schmitz-Dräger, B.J. (2019). New horizons in bladder cancer research. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.12.014
Williams, S.B., Hudgins, H.K., Ray-Zack, M.D., Chamie, K., Smaldone, M.C., Boorjian, S.A.,... Gore, J.L. (2019). Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. European Urology Oncology, 2(2), 119-125. https://dx.doi.org/10.1016/j.euo.2018.07.006
Yao, J.C., Strosberg, J., Fazio, N., Pavel, M.E., Ruszniewski, P., Bergsland, E.,... Singh, S. (2018). Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx). In ANNALS OF ONCOLOGY. Munich, DE: OXFORD: OXFORD UNIV PRESS.
Capper, D., Jones, D.T.W., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D.,... Pfister, S.M. (2018). DNA methylation-based classification of central nervous system tumours. Nature, 555(7697), 469-474. https://dx.doi.org/10.1038/nature26000
Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R., & Schmitz-Draeger, B.J. (2018). Editorial: Managing locally advanced bladder cancer. Third International Bladder Cancer Network seminars series. Urologic Oncology-Seminars and Original Investigations, 36(9), 403-404. https://dx.doi.org/10.1016/j.urolonc.2017.11.006
Yao, J.C., Fazio, N., Li, D., Pavel, M.E., Strosberg, J., Bergsland, E.,... Singh, S. (2018). ElevatION: NET-201 A Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients with Metastatic, Well-Differentiated NET of Pancreatic/GI/Thoracic Origin or Poorly-Differentiated GEP NEC Who Have Progressed on Prior Treatment. (pp. 218-218).
Brabletz, T., Kalluri, R., Nieto, M.A., & Weinberg, R.A. (2018). EMT in cancer. Nature Reviews Cancer, 18(2), 128-134. https://dx.doi.org/10.1038/nrc.2017.118
El Hallani, S., Udager, A.M., Bell, D., Fonseca, I., Thompson, L.D.R., Assaad, A.,... Chiosea, S. (2018). Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. American Journal of Surgical Pathology, 42(1), 18-27. https://dx.doi.org/10.1097/PAS.0000000000000933
Schäffner, I., Minakaki, G., Khan, M.A., Balta, E.-A., Schlötzer-Schrehardt, U., Schwarz, T.J.,... Lie, D.C. (2018). FoxO Function Is Essential for Maintenance of Autophagic Flux and Neuronal Morphogenesis in Adult Neurogenesis. Neuron, 99(6), 1188-1203.e6. https://dx.doi.org/10.1016/j.neuron.2018.08.017
Pachera, E., Assassi, S., Salazar, G., Frank-Bertoncelj, M., Distler, J., Kania, G., & Distler, O. (2018). LONG NONCODING RNA H19X IS A MASTER REGULATOR OF EXTRACELLULAR MATRIX PRODUCTION IN SYSTEMIC SCLEROSIS. (pp. A10-A11).
Hurvitz, S.A., Martin, M., Symmans, W.F., Jung, K.H., Huang, C.-S., Thompson, A.M.,... Slamon, D. (2018). Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncology, 19(1), 115-126. https://dx.doi.org/10.1016/S1470-2045(17)30716-7

Last updated on 2016-21-04 at 08:24